Table 3.
Summary of molecular genetic alterations
| Tumor no. | DI | MSI | MSH2 | MLH1 | B-cat. | TP53 | KRAS mut. |
| 1 | 2.1 | - | + | + | C | - | - |
| 2 | 1.1 | - | + | + | C | - | - |
| 3 | 1.4 | - | + | + | C | + | 12, GGT->GAT |
| 4 | 4.5 | - | + | + | C | + | 12, GGT->GTT |
| 5 | 2.0 | - | + | + | C | + | - |
| 6 | 1.4 | - | + | + | C | + | 12, GGT->TGT |
| 7 | 1.7 | - | + | + | C | - | - |
| 8 | 1.0 | + | - | + | M | - | - |
| 9 | 1.5 | - | + | + | M | + | - |
| 10 | 1.0 | + | - | + | C | + | 13, GGC->GAC |
| 11 | 1.0 | - | + | + | C | - | - |
| 12 | 1.0 | + | - | + | N | - | - |
| 13 | 1.6 | - | + | + | C | - | - |
| 14 | 1.0 | - | + | + | N | + | - |
| 15 | 1.0 | - | + | + | C | + | - |
| 16 | 1.0 | - | + | + | M | + | - |
| 17 | 1.0 | - | + | + | M | - | - |
| 18 | 1.1 | - | + | + | C | + | - |
| 19 | 1.1 | - | + | + | C | + | - |
| 20 | 1.3 | - | + | + | N | - | - |
| 21 | 1.8 | - | + | + | C | + | - |
| 22 | 1.3 | - | + | + | N | - | - |
| 23 | 1.2 | - | + | + | C | - | - |
| 24 | 1.7 | - | + | + | N | - | - |
| 25 | 1.0 | - | + | + | M | + | - |
| 26 | 2.0 | - | + | + | N | + | - |
| 27 | 1.2 | - | + | + | C | + | 12, GGT->GAT |
| 28 | 1.6 | - | + | + | C | + | - |
| 29 | 1.2 | - | + | + | C | + | 12, GGT->AGT |
| 30 | 1.1 | - | + | + | C | + | - |
Abbreviations: DI: DNA index C:cytoplasmic, M:membraneous, N:nuclear